Jump Financial’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
Jump Financial's BEAM Position: Q2 2026 in Review
Jump Financial sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 89,386 shares — an estimated $2.13M sold.
Jump Financial first reported a position in BEAM in Q1 2021 and held it in 11 quarters. The position peaked at $3.51M in Q3 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Jump Financial reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jump Financial sold 89,386 Beam Therapeutics shares in Q2 2026, an estimated $2.13M.
- Jump Financial first reported a position in Beam Therapeutics in Q1 2021 and held it in 11 quarters.
- Jump Financial's Beam Therapeutics position peaked at $3.51M in Q3 2025.
- 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.